CLDN11 and gastric cancer: Our bisulfite sequencing analysis demonstrated that the hypermethylated CLDN11 promoter region is located at − 137 to + 405, similar to previously reported differentially hypermethylated region in gastric cancer (− 104 to + 4) [23] and in melanoma (+ 144 to + 249) [33].